Studies tumour tissue and blood samples in people with colorectal cancer
Collects tumour biopsies and blood samples from adults with colorectal cancer during their care.
Plain-language title generated from the registry record
Registry title: Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response
Key facts
- Where
- Gothenburg, SwedenSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with colorectal cancer who are seen or treated at Sahlgrenska University Hospital. Samples are taken to study the tumour and how it responds to treatment.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Colorectal cancer; no specific stage is named
Main reasons for not taking part
- Cancer that is not colorectal cancer
Read by machine on 9 November 2026.
Where in Sweden
- Dept. of Surgery, Sahlgrenska University Hospital/OstraGothenburg, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sahlgrenska University Hospital
- Trial code
- NCT04130971
- Record updated
- 7 November 2023
- Original description
All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams.Read full original descriptionShow less
Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment
All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams.
Blood samples and in relevant cases urinary samples and mouth swabs will be taken at all timepoints when biopsies are taken. If it is not possible to take biopsies prior treatment blood samples will still be drawn.
Inclusion: Colorectal cancer.
Exclusion: Not colorectal cancer.